PMID: 8610092Apr 2, 1996Paper

Barriers to protein folding: formation of buried polar interactions is a slow step in acquisition of structure

Proceedings of the National Academy of Sciences of the United States of America
C D WaldburgerR T Sauer

Abstract

In the MYL mutant of the Arc repressor dimer, sets of partially buried salt-bridge and hydrogen-bond interactions mediated by Arg-31, Glu-36, and Arg-40 in each subunit are replaced by hydrophobic interactions between Met-31, Tyr-36, and Leu-40. The MYL refolding/dimerization reaction differs from that of wild type in being 10- to 1250-fold faster, having an earlier transition state, and depending upon viscosity but not ionic strength. Formation of the wild-type salt bridges in a hydrophobic environment clearly imposes a kinetic barrier to folding, which can be lowered by high salt concentrations. The changes in the position of the transition state and viscosity dependence can be explained if denatured monomers interact to form a partially folded dimeric intermediate, which then continues folding to form the native dimer. The second step is postulated to be rate limiting for wild type. Replacing the salt bridge with hydrophobic interactions lowers this barrier for MYL. This makes the first kinetic barrier rate limiting for MYL refolding and creates a downhill free-energy landscape in which most molecules which reach the intermediate state continue to form native dimers.

References

Jun 2, 1992·Biochemistry·P BryanD T Gallagher
Sep 5, 1989·Biochemistry·J U Bowie, R T Sauer
Jan 1, 1985·Annual Review of Biophysics and Biophysical Chemistry·O G Berg, P H von Hippel
Mar 15, 1984·Journal of Molecular Biology·A A Rashin, B Honig
Aug 1, 1995·Nature Structural Biology·T SchindlerF X Schmid
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·G S Huang, T G Oas
Mar 1, 1994·Nature Structural Biology·T R SosnickS W Englander
Mar 1, 1994·Nature Structural Biology·B M BrownR T Sauer
Jan 1, 1993·Annual Review of Biophysics and Biomolecular Structure·F X Schmid
Feb 1, 1995·Nature Structural Biology·C D WaldburgerR T Sauer
Mar 15, 1994·Structure·D A RozwarskiP A Karplus
Dec 1, 1993·Protein Science : a Publication of the Protein Society·M E MillaR T Sauer
Jan 1, 1993·Annual Review of Biochemistry·C R Matthews
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A Matouschek, A R Fersht
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·X PengJ L Silva

❮ Previous
Next ❯

Citations

Feb 1, 1997·Protein Science : a Publication of the Protein Society·J A Rank, D Baker
Jul 1, 1997·Protein Science : a Publication of the Protein Society·Y BaiP E Wright
Apr 1, 1998·Protein Science : a Publication of the Protein Society·R V Pappu, D L Weaver
Jun 28, 2005·Archives of Biochemistry and Biophysics·Christopher BrownPernilla Wittung-Stafshede
Dec 19, 2002·Biophysical Chemistry·Alok K Srivastava, Robert T Sauer
Feb 1, 1997·Current Opinion in Structural Biology·H Roder, W Colón
Mar 31, 1998·Current Opinion in Structural Biology·K W PlaxcoD Baker
Mar 31, 1998·Current Opinion in Structural Biology·A P Capaldi, S E Radford
Apr 1, 1997·Nature Structural Biology·R E BurtonT G Oas
Mar 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Wei WangP G Wolynes
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·J A McCammon
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·S J HagenW A Eaton
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·R L Baldwin
Sep 18, 2009·The Journal of Biological Chemistry·Kate L Moreau, Jonathan King
Mar 29, 2001·Protein Science : a Publication of the Protein Society·D H KimK Y Choi
Jun 5, 2002·Annual Review of Biochemistry·Jeffrey K Myers, Terrence G Oas
Jun 4, 1999·Biological Chemistry·M W Lassalle, H J Hinz
May 27, 1997·Proceedings of the National Academy of Sciences of the United States of America·M JacobF X Schmid
Dec 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yongjin ZhuFeng Gai
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·M L Scalley, D Baker
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·B M Brown, R T Sauer
Sep 15, 1999·Proceedings of the National Academy of Sciences of the United States of America·L B MoranT R Sosnick
Nov 5, 1999·Journal of Molecular Biology·S Kumar, R Nussinov
Jul 5, 2005·Expert Opinion on Investigational Drugs·C R Middaugh, K L Edwards
Jan 12, 2016·Journal of the American Chemical Society·Caitlin M Davis, R Brian Dyer
Sep 5, 2002·Proteins·Tobin R SosnickAriel Fernández
Dec 2, 2011·Current Opinion in Structural Biology·Thomas KiefhaberKristine Steen Jensen
Jul 24, 2007·Biochimica Et Biophysica Acta·Hugo NájeraD Alejandro Fernández-Velasco
Mar 23, 2004·Journal of Molecular Biology·Sarah GütheThomas Kiefhaber
Jul 16, 2005·Proteins·James N Sarakatsannis, Yong Duan
Apr 13, 2004·Protein Science : a Publication of the Protein Society·Neil BascosPernilla Wittung-Stafshede
Aug 22, 2013·Protein Science : a Publication of the Protein Society·Robert T Sauer
Oct 27, 2004·Journal of Molecular Biology·Patrik ForrerAndreas Plückthun
Jun 9, 2004·Journal of Molecular Biology·Olga Esteban, Huimin Zhao
Jul 19, 2005·Journal of Molecular Biology·Gonzalo de Prat-GayYu-Keung Mok
Aug 26, 1998·Folding & Design·S E Jackson
Jan 1, 1996·Folding & Design·R T Sauer
Jan 1, 1997·Folding & Design·A G LadurnerA R Fersht

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.